UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 861177 NEW YORK, NY

Back to FULC Full portfolio

Position in FULC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,829

-$3,099 QoQ

Shares Held

773

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#136

of 154 holders

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in FULC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. FULC ranks #183 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,086,683	$1,533,248,041
2	REGN	Regeneron Pharmaceuticals, Inc.	716,560	$446,803,817
3	ALNY	Alnylam Pharmaceuticals, Inc.	727,848	$219,104,078
4	INCY	Incyte Corp	1,508,720	$171,028,494
5	RVMD	Revolution Medicines, Inc.	912,335	$170,862,094
6	INSM	INSMED Inc	1,335,071	$142,345,265
7	IONS	Ionis Pharmaceuticals Inc	1,454,672	$115,340,938
8	MRNA	Moderna, Inc.	1,521,849	$106,575,080

All Filings in FULC

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,829	773	0.0%	Shares	Defined	2026-08-13
2026-03-31	$5,928	773	+9.0%	Shares	Defined	2026-05-13
2025-12-31	$8,018	709	+0.9%	Shares	Defined	2026-02-13
2025-03-31	$2,024	703	-97.3%	Shares	Defined	2025-05-19
2023-06-30	$84,806	25,699	0.0%	Shares	Sole	2023-08-11
2023-03-31	$73,242	25,699	+73.6%	Shares	Sole	2023-05-15
2022-12-31	$107,744	14,800	0.0%	Shares	Sole	2023-02-14
2022-09-30	$119,732	14,800	0.0%	Shares	Sole	2022-11-14
2022-06-30	$72,520	14,800	0.0%	Shares	Sole	2022-08-12
2022-03-31	$350,020	14,800	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.